Soft tissue sarcoma - Treatment with immunosuppressive drugs Factor
Last reviewed for CCPS 20 August 2008.
Investigative Documents
Medical Report - Treatment with Immunosuppressive Drugs - Soft Tissue Sarcoma [MR9341]
Preliminary questions [30685]
there is some evidence that treatment with immunosuppressive drugs may be a factor in the development of the condition under consideration.34536 the veteran has been treated with immunosuppressive drugs at some time.
the veteran has been treated with immunosuppressive drugs for a continuous period of at least five months at some time. the treatment with immunosuppressive drugs for a continuous period of at least five months was materially contributed to by treatment of an illness or injury which is identifiable.30717 — the veteran has established the causal connection between the treatment with immunosuppressive drugs and VEA service for the clinical onset of soft tissue sarcoma.
30718 — the veteran has established the causal connection between the treatment with immunosuppressive drugs and operational service for the clinical onset of soft tissue sarcoma.
or
30719 — the veteran has established the causal connection between the treatment with immunosuppressive drugs and eligible service for the clinical onset of soft tissue sarcoma.
Clinical onset and operational service [30718]
the identified illness or injury made a material contribution to the veteran being treated with immunosuppressive drugs for a continuous period of at least five months before the clinical onset of the condition under consideration.36205 — the identified illness or injury which made a material contribution to the veteran being treated with immunosuppressive drugs for a continuous period of at least five months is causally related to operational service.
Clinical onset and eligible service [30719]
the identified illness or injury was treated with cyclophosphamide or a drug used for the purpose of suppressing the immune responses after organ transplantation, which are the immunosuppressive drugs available in eligible service cases. the identified illness or injury made a material contribution to the veteran being treated with immunosuppressive drugs for a continuous period of at least five months before the clinical onset of the condition under consideration.36206 — the identified illness or injury which made a material contribution to the veteran being treated with immunosuppressive drugs for a continuous period of at least five months is causally related to eligible service.